1. Home
  2. GL vs ELAN Comparison

GL vs ELAN Comparison

Compare GL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$154.17

Market Cap

11.9B

Sector

Finance

ML Signal

HOLD

Logo Elanco Animal Health Incorporated

ELAN

Elanco Animal Health Incorporated

HOLD

Current Price

$24.17

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
ELAN
Founded
1900
1954
Country
United States
United States
Employees
3695
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
12.7B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GL
ELAN
Price
$154.17
$24.17
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$167.27
$27.89
AVG Volume (30 Days)
440.6K
6.6M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
0.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.11
Revenue
N/A
$4,715,000,000.00
Revenue This Year
$9.64
$8.21
Revenue Next Year
$5.61
$5.31
P/E Ratio
$10.21
$214.77
Revenue Growth
N/A
6.22
52 Week Low
$116.73
$13.09
52 Week High
$157.92
$27.72

Technical Indicators

Market Signals
Indicator
GL
ELAN
Relative Strength Index (RSI) 52.25 59.78
Support Level $150.88 $23.72
Resistance Level $155.60 $25.78
Average True Range (ATR) 3.31 1.12
MACD -0.30 0.33
Stochastic Oscillator 57.46 90.73

Price Performance

Historical Comparison
GL
ELAN

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Share on Social Networks: